Sonja C. Schriever

Sonja C. Schriever

Auto-generated profile, based on publicly available information

Sonja C. Schriever

German Center for Diabetes Research (DZD)

Research Focus & Metrics

Academic Career Length

18Years (2009-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
11 November 2012 in Nature Medicine
Verified
Journal Article
Closed access
PDF file
BFBrian Finan
Brian Finan
BYBin Yang
Bin Yang
NONickki Ottaway
Nickki Ottaway
KSKerstin Stemmer
Kerstin Stemmer
TMTimo D Müller
Timo D Müller
MTMatthias H Tschöp
Matthias H Tschöp

28 October 2013 in Glia
Verified
Journal Article
Closed access
PDF file
YGYuanqing Gao
Yuanqing Gao
NONickki Ottaway
Nickki Ottaway
SSSonja C. Schriever
Sonja C. Schriever
BLBeata Legutko
Beata Legutko
CGCristina García-Cáceres
Cristina García-Cáceres
CYChun-Xia Yi
Chun-Xia Yi

13 March 2014 in Diabetes
Verified
Journal Article
Open access
CCChristoffer Clemmensen
Christoffer Clemmensen
JCJoseph Chabenne
Joseph Chabenne
BFBrian Finan
Brian Finan
LSLorraine Sullivan
Lorraine Sullivan
KFKatrin Fischer
Katrin Fischer
TMTimo D. Müller
Timo D. Müller
We recently reported restoration of leptin responsiveness in diet-induced obese (DIO) mice using a pharmacologically optimized, polyethylene-glycolated (PEG)-leptin analog in combination with exendin-4 or FGF21. However, the return of leptin action required discontinuation of high-fat diet (HFD) exposure. Here we assess whether a single peptide possessing balanced coagonism at the glucagon-like peptide 1 (GLP-1) and glucagon receptors can restore leptin responsiveness in DIO mice maintained on a HFD. DIO mice were treated with PEG-GLP-1/glucagon (30 nmol/kg every fourth day) to induce an ∼15% body weight loss, upon which they were randomized to continue PEG-GLP-1/glucagon therapy or reassigned to receive supplemental daily PEG-leptin (185 nmol/kg/day). The addition of PEG-leptin to PEG-GLP-1/glucagon resulted in an ∼18% greater weight loss as compared with PEG-GLP-1/glucagon alone and was accompanied by further decreases in food intake and improved glucose and lipid metabolism. The beneficial effect of PEG-leptin supplementation occurred after an initial body weight loss similar to what we previously reported following reduced dietary fat along with PEG-leptin and exendin-4 or FGF21 cotreatment. In summary, we report that GLP-1/glucagon coagonism restores leptin responsiveness in mice maintained on a HFD, thus emphasizing the translational value of this polypharmacotherapy for the treatment of obesity and diabetes.

21 December 2012 in Journal of Clinical Investigation
Verified
Journal Article
Open access
PDF file
TMTimo D. Müller
Timo D. Müller
SLSang Jun Lee
Sang Jun Lee
MJMartin Jastroch
Martin Jastroch
DKDhiraj Kabra
Dhiraj Kabra
KSKerstin Stemmer
Kerstin Stemmer
MTMatthias H. Tschöp
Matthias H. Tschöp
The scaffold protein p62 (sequestosome 1; SQSTM1) is an emerging key molecular link among the metabolic, immune, and proliferative processes of the cell. Here, we report that adipocyte-specific, but not CNS-, liver-, muscle-, or myeloid-specific p62-deficient mice are obese and exhibit a decreased metabolic rate caused by impaired nonshivering thermogenesis. Our results show that p62 regulates energy metabolism via control of mitochondrial function in brown adipose tissue (BAT). Accordingly, adipocyte-specific p62 deficiency led to impaired mitochondrial function, causing BAT to become unresponsive to β-adrenergic stimuli. Ablation of p62 leads to decreased activation of p38 targets, affecting signaling molecules that control mitochondrial function, such as ATF2, CREB, PGC1α, DIO2, NRF1, CYTC, COX2, ATP5β, and UCP1. p62 ablation in HIB1B and BAT primary cells demonstrated that p62 controls thermogenesis in a cell-autonomous manner, independently of brown adipocyte development or differentiation. Together, our data identify p62 as a novel regulator of mitochondrial function and brown fat thermogenesis.

1 January 2014 in Analytical Biochemistry
Verified
Journal Article
Closed access
MDManuel J. Deutsch
Manuel J. Deutsch
SSSonja C. Schriever
Sonja C. Schriever
ARAdelbert A. Roscher
Adelbert A. Roscher
RERegina Ensenauer
Regina Ensenauer

1 November 2015 in Cell Metabolism
Verified
Journal Article
Closed access
PPPaul T. Pfluger
Paul T. Pfluger
DKDhiraj G. Kabra
Dhiraj G. Kabra
MAMichaela Aichler
Michaela Aichler
SSSonja C. Schriever
Sonja C. Schriever
KPKatrin Pfuhlmann
Katrin Pfuhlmann
MTMatthias H. Tschöp
Matthias H. Tschöp